Financhill
Back

Target Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
43

TGT
Target

Last Price:
146.20
Seasonality Move:
1.74%
Sell
44

RARE
Ultragenyx Pharmaceutical

Last Price:
40.75
Seasonality Move:
-0.9%
Sell
43
Target (TGT) is a Sell

Is Target a Buy, Sell or Hold?

  • The current Target [TGT] share price is $147.17. The Score for TGT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • TGT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $40.50. The Score for RARE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TGT Stock Price Chart

What is Target's stock price today?

  • The Target share price today is $147.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TGT is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $40.50
    The current trend is relatively stagnant and RARE is experiencing slight buying pressure.

TGT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.31 Sell
Relative Strength Index (14 RSI): 46.98 Sell
Chaikin Money Flow: 2160081 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (143.53 - 150.83) Sell
Bollinger Bands (100): (147.52 - 168.4) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.6 Sell
Relative Strength Index (14 RSI): 49.22 Sell
Chaikin Money Flow: 494801 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.79 - 41.97) Buy
Bollinger Bands (100): (40.81 - 48.79) Sell

TGT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 145.23 Buy
20-day SMA: 147.19 Sell
50-day SMA: 154.57 Sell
200-day SMA: 141.73 Buy
8-day EMA: 146.38 Buy
20-day EMA: 147.68 Sell
50-day EMA: 152.29 Sell
200-day EMA: 149.12 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.2 Buy
20-day SMA: 40.42 Buy
50-day SMA: 41.53 Sell
200-day SMA: 42.45 Sell
8-day EMA: 39.89 Buy
20-day EMA: 40.39 Buy
50-day EMA: 41.79 Sell
200-day EMA: 43.35 Sell

Target Earnings Growth & TGT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.80 per share, an increase next quarter of $0.20 per share, an increase this year of $2.81 per share, and an increase next year of $1.01 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Target Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):